83 related articles for article (PubMed ID: 11749069)
1. Differential response to Tat and FGF-2 of two novel clonal populations derived from murine Kaposi-like lesions developing in Tat transgenic mice.
Wu Z; Mariotti M; Cavallaro U; Soria MR; Maier JA
Microvasc Res; 2002 Jan; 63(1):19-26. PubMed ID: 11749069
[TBL] [Abstract][Full Text] [Related]
2. Exogenous fibroblast growth factor-2 induces a transformed phenotype in vascular kaposi's sarcoma-like cells.
Cavallaro U; Soria MR; Montesano R
Mol Cell Biol Res Commun; 2000 Oct; 4(4):203-5. PubMed ID: 11409912
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.
Wu Z; Cavallaro U; Marchisio PC; Soria MR; Maier JA
Am J Pathol; 1998 Jun; 152(6):1599-605. PubMed ID: 9626063
[TBL] [Abstract][Full Text] [Related]
5. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
6. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
[TBL] [Abstract][Full Text] [Related]
7. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
Fiorelli V; Gendelman R; Samaniego F; Markham PD; Ensoli B
J Clin Invest; 1995 Apr; 95(4):1723-34. PubMed ID: 7535796
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis.
Fiorelli V; Barillari G; Toschi E; Sgadari C; Monini P; Stürzl M; Ensoli B
J Immunol; 1999 Jan; 162(2):1165-70. PubMed ID: 9916748
[TBL] [Abstract][Full Text] [Related]
9. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions.
Taraboletti G; Benelli R; Borsotti P; Rusnati M; Presta M; Giavazzi R; Ruco L; Albini A
J Pathol; 1999 May; 188(1):76-81. PubMed ID: 10398144
[TBL] [Abstract][Full Text] [Related]
12. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma.
Ensoli B; Gendelman R; Markham P; Fiorelli V; Colombini S; Raffeld M; Cafaro A; Chang HK; Brady JN; Gallo RC
Nature; 1994 Oct; 371(6499):674-80. PubMed ID: 7935812
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of AIDS-associated Kaposi's sarcoma.
Ensoli B; Barillari G; Gallo RC
Hematol Oncol Clin North Am; 1991 Apr; 5(2):281-95. PubMed ID: 2022594
[TBL] [Abstract][Full Text] [Related]
14. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo RC; Ensoli B
J Immunol; 1992 Dec; 149(11):3727-34. PubMed ID: 1431144
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
[TBL] [Abstract][Full Text] [Related]
16. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis and modulation by HIV-Tat of the tyrosine phosphatase HD-PTP.
Mariotti M; Castiglioni S; Maier JA
J Cell Biochem; 2006 May; 98(2):301-8. PubMed ID: 16408268
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 induces an autocrine loop hepatocyte growth factor/c-Met in murine Kaposi-like spindle cells.
Maier J; Mariotti M; Comoglio PM; Soria MR
Oncogene; 1996 Sep; 13(5):1009-15. PubMed ID: 8806690
[TBL] [Abstract][Full Text] [Related]
19. Spindle cells isolated from Kaposi's sarcoma-like lesions of BKV/tat-transgenic mice co-express markers of different cell types.
Cavallaro U; Gasparini G; Soria MR; Maier JA
AIDS; 1996 Sep; 10(11):1211-9. PubMed ID: 8883582
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
